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ABSTRAK
PENDAHULUAN
Glaukoma adalah penyakit kronik yang memerlukan rawatan sepanjang hidup. Kualiti
hidup pesakit glaukoma kerap tidak dititikberatkan dalam rawatan penyakit tersebut.
Pemahaman mengenai kualiti hidup dan saringan awal kemurungan pesakit glaukoma
primer membantu dalam rawatan penyakit. Di Malaysia, masih terdapat jurang dalam
pemahaman  mengenai  kualiti  hidup  dan  kemurungan  di  antara  pesakit  geriatrik
glaukoma primer.
OBJEKTIF
Menilai  kualiti  hidup dan kemurungan  di  antara  pesakit  glaucoma primer  dengan
menggunakan borang soal selidik skala glaucoma QoL 36 (GlauQoL 36) dan skala
kemurungan geriatric 14 (mGDS 14). Kajian ini juga cuba untuk mengaitkan kualiti
hidup dan kemurungan  dengan tahap glaukoma.  Korelasi  antara  kualiti  hidup dan
kemurungan juga di kaji.
METODOLOGI
xiv
Suatu kajian keratan rentas bandingan telah dijalankan di Hospital Universiti Sains
Malaysia, Kelantan dan Hospital Selayang, Selangor di antara Julai 2014 dan Februari
2016. Pesakit POAG yang melebihi 60 tahun pada waktu kajian telah direkrut. Pesakit
mempunyai  mLOCS II gred 1 atau kurang, menjalani  pembedahan trabeculektomi
atau  katarak  sekurang  kurangnya  3  bulan  sebelum kajian  dan  sedang  mengambil
rawatan  untuk  glaukoma  primer.  Tahap  glaukoma  primer  adalah  berdasarkan
‘Advanced Glaucoma Intervention Study’ (AGIS) menggunakan dua analisis medan
penglihatan Humphrey SITA program 24-2 yang dipercayai.  Temuduga bersemuka
dijalankan menggunakan borang soal selidik GlauQoL 36 dan mGDS 14 yang telah
divalidasi.
KEPUTUSAN
Seramai 360 pesakit telah menyertai kajian ini. Kebanyakan pesakit di antara umur
60-69  (38.3%).  Secara  keseluruhan,  64  (17.8%)  menghidapi  glaucoma  ringan,  93
(25.8%) menghidapi glaucoma sederhana, 115 (31.9%) menghidapi glaucoma teruk
dan  88  (24.4%)  menghidapi  glaucoma  peringkat  akhir.  Kebanyakan  pesakit  tidak
berkerja  (88.9%)  dan  tinggal  bersama  keluarga  (68.1%).  Perbezaan  statistik
signifikasi diperolehi di antara semua domain borang soal selidik GlauQoL 36 dan
tahap glaukoma primer: kehidupan seharian, memandu, jiwa, imej diri, kebimbangan,
halangan dan sokongan. Kualiti kehidupan menurun apabila tahap glaucoma primer
semakin naik dalam semua domain kecuali domain sokongan. Terdapat lebih ramai
pesakit dengan kemurungan apabila tahap glaukoma meningkat. Korelasi yang lemah
diperolehi di antara kualiti hidup dan kemurungan di antara kumpulan POAG (r <
0.25).
xv
KESIMPULAN
Versi Bahasa Malaysia GlauQoL 36 dan mGDS 14 adalah alat yang berguna dalam
mengkaji  kualiti  hidup dan kemurungan pesakit  POAG di Malaysia.  Kualiti  hidup
berkurangan apabila tahap glaukoma semakin meningkat. Kemurungan adalah lebih
tinggi  dalam  tahap  glaukoma  teruk.  Bagaimanapun,  korelasi  lemah  diperolehi  di
antara kualiti hidup dan kemurungan.
xvi
ABSTRACT
INTRODUCTION
Glaucoma is a chronic disease requiring life long treatment. Quality of life (QoL) is
often under emphasized during the course of glaucoma management. Understanding
the  quality  of  life  and detection  of  early  depression  at  different  severity  stage  of
POAG not only helps in coping with the disease but also in customization of the
management. There is still a wide gap in understanding the QoL and depression in
elderly with POAG in Malaysia.
 
OBJECTIVE
To  evaluate  quality  of  life  and  depression  in  patients  with  primary  open  angle
glaucoma using the Malay version of the Glaucoma Quality of Life- 36 (Glau-QoL
36) and malay version Geriatric Depression Scale 14 (mGDS 14) questionnaires. This
study also aims to compare  the QoL and depression with severity of POAG. The
potential correlation between QoL and depression was also studied.
METHODS
xvii
A  cross  sectional  study  was  conducted  in  Hospital  Universiti  Sains  Malaysia,
Kelantan and Hospital  Selayang,  Selangor between July 2014 and February 2016.
POAG patients who were  ≥ 60 years old at the time of recruitment had mLOCS II
grade 1 or less, underwent cataract or trabeculectomy surgery at least 3 months prior
and were on medical or combined medical and surgical treatment. Severity of POAG
was based on modified Advanced Glaucoma Intervention Study (AGIS) based on two
reliable reproducible Humphrey visual field SITA program 24-2 analysis. Face to face
interview was conducted using validated Bahasa Malaysia version of GlauQol 36 and
mGDS 14 questionnaires.
RESULTS
A total of 360 patients were recruited. Majority of recruited patients were between
ages 60-67 (38.3%). Overall 64 (17.8%) have mild POAG, 93 (25.8%) have moderate
POAG, 115 (31.9%) have  severe  POAG and 88 (24.4%) have  end  stage  POAG.
Majority  of  the  recruited  patients  were  not  working  (88.9%)  and  live  with  their
families  (68.1%).  There  was  significant  association  between  GlauQoL  36  score
among  POAG  patients  according  to  severity  and  domains:  daily  living,  driving,
physiological well being, self image, anxiety, burden of treatment and confidence in
healthcare. Increased severity of POAG was associated with dectresed quality of life
in  all  GlauQoL  36  domains  except  confidence  in  healthcare.  There  were  more
depressive  patients  as  severity  of  POAG  increased.  There  was  poor  correlation
between quality of life and depression among POAG patients ( r <0.25).
CONCLUSION
xviii
Bahasa Malaysia version of GlauQoL 36 and mGDS 14 is a useful tool to assess QoL
and depression of POAG patients in Malaysia. GlauQoL 36 scores increased as the
severity of glaucoma increases suggestive of poorer quality of life. The mGDS 14
score also increases as the severity of glaucoma increases. However, there was poor
correlation between QoL and depression based on the mGDS 14 and GlauQoL 36
questionnaire.
xix
GLAUCOMA
Glaucoma is a group of disease that causes progressive damage to the optic nerve,
which left untreated gradually progresses to visual damage and may lead to blindness
(World Glaucoma Association, 2015).
However, from the early 1880’s until last quarter of the 20th century, glaucoma was
defined  as  ‘pressure  within  the  eye  higher  than  the  statistical  normal  of  the
population’ (Von Graefe A & Windsor T, 1859; Keyser PD, 1864). This concept as a
defining characteristic for glaucoma has been almost universally discarded. This is
based  on  studies  documenting  disc  and  field  damage  in  people  with  statistically
normal intraocular pressure (Foster & Quigley, 2002). 
Glaucoma is the second most common cause of blindness in the world with nearly 66
million people suffering from this chronic ophthalmologic condition (Weinreb RN &
Khaw PT, 2004; Quigley HA & Broman AT, 2006). It is projected to become the
most  common  cause  of  blindness  worldwide (Vanderbroeck  S  et  al,  2011).  The
number with open angle glaucoma in 2010 was highest among European population
(23.9%) compared to Asians (4.7%) (Quigley HA & Broman AT, 2006). It has been
projected that by 2020 the number of open angle glaucoma patients in Asian regions
will increase to 5.2%; an increase of 1 million people (Quigley HA & Broman AT,
2006). The global glaucoma blindness is estimated to be 5.2 million people (15%)
(Thylefors  B & Negrel A-D, 1994).  Blindness in the European population ranged
from 2.5 to 8% whereas in African Americans it was 8.0% (Thylefors B et al, 1992).
A study conducted in Singapore documented  the rate  of uniocular  blindness from
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POAG to be 27% and PACG 50% while binocular blindness is 9% for POAG and
29% for PACG (Foster PJ et al, 2000).
Glaucoma can be classified into 2 broad groups based on the angle structures; open
and  closed  angle  glaucoma.  This  can  be  further  subdivided  into  primary  and
secondary glaucoma (Quigley HA, 1996). The prevalence of each type of glaucoma
varies according to the region with open angle glaucoma having an equal distribution
while closed angle closure glaucoma is more prevalent in Asia (Quigley HA, 1996).
Glaucoma  often  requires  lifelong  treatment  and  carries  a  risk  of  serious  visual
impairment. Patients’ may experience progressive worsening of their vision, initially
peripherally  but  eventually  involving  the  central  vision  (Khadka  J  et  al,  2013).
Advancing age is strongly correlated with the progression of glaucoma to blindness in
both eyes as well as in at least one eye (Hattenhauer et al, 1998; Jacob A et al, 1998;
Dandona L et al, 2000). It has been estimated that a probability of 9% for bilateral
blindness  and  a  27%  for  unilateral  blindness  in  open  angle  glaucoma  patients
(Hattenhauer et al, 1998).
Traditionally,  evaluation  of  outcomes  in  glaucoma  clinical  trials  has  focused  on
clinical measures of glaucoma status, mainly the extent of visual field loss and level
of  intraocular  pressure measurement.  However,  such measures  do  not  capture  the
effects of glaucoma or its treatment on activity limitation and wellbeing (Che Hamzah
J et al, 2011). The effects of glaucoma on well being are better assessed by outcomes
reported by glaucoma patients in the form of questionnaires as it is able to capture the
effect of glaucoma on their daily living.
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1.1 PRIMARY OPEN ANGLE GLAUCOMA
POAG is characterized as a chronic, slowly progressive visual field loss and optic
nerve  cupping,  often  associated  with  an  elevated  IOP with visually  open anterior
chamber  angles  by  gonioscopy,  without  underlying  secondary  ocular  disease
(European Glaucoma Society, 2014).
Glaucoma is a disease of longevity. Advancing age is a risk factor for POAG (Jacob
A et al, 1998; Ramakrishnan R et al, 2003; Leske MC et al, 2001). The mean age of
developing  glaucoma  is  68.1  (4.9  SD)  years  (Leske  MC  et  al,  1999).  Due  to
improvement of life expectancy and healthcare, the number of people with glaucoma
is expected to rise; which poses a substantial public health challenge worldwide (Ying
P and Varma,  2011).  Increasing  age  is  known to  increase  the  risk  of  developing
glaucoma in  individuals  with  elevated  intraocular  pressure and for  progression  of
glaucoma  (Leske  MC et  al,  2007;  Gordon  MO et  al,  2002;  European  Glaucoma
Prevention Study Group, 2007). The hazards ratio is 1.32 per decade (95% CI; 1.17,
1.71)  (European Glaucoma Prevention  Study Group, 2007).  In the Early Manifest
Glaucoma Trial, faster and greater progression was noted in older patients (> 68 years
of age) when compared to younger patients (Leske MC et al, 1999).
Barbados Eye Study found an increase of 2.5 times from 1.2% at ages 40-49 to 4.2%
at the age of 70 and above (Leske MC et al, 2001). The Kandy Eye Study found that
in Sri Lanka patients 70 years and above were six times more likely to develop POAG
as compared to those in their fourth decade (p=0.003) (Sia DI et al, 2010). In a study
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conducted in Japan, older age groups had OR of 1.06 (95% CI; 1.04, 1.08) to develop
POAG (Suzuki Y et al, 2006).
Although glaucoma encompasses  a  diverse  group of  disease,  its  hallmark  include
progressive irreversible damage to the optic nerve head and the retinal ganglion cells
with  corresponding visual  field  loss  (Tuulonen  A and Airaksinen PJ,  1991).  This
results in progressive and asymmetric changes in the optic cup, with corresponding
visual field loss. Typically, structural changes occur before functional loss (Tuulonen
A and Airaksinen PJ, 1991).
The cardinal  features  of open angle glaucoma at the optic  disc are a  reduction in
neuroretinal rim area and enlargement of the optic cup; both of which are related to
the age of the individual (Garway-Heath D F et al, 1997). A number of histological
studies have found an age related decline in optic nerve axon count, with an estimated
rate of decline around 0.36% to 0.62% per year (Balazsi AG et al, 1984; Johnson BM
et  al,  1987;  Jonas  JB  et  al,  1990).  Faster  progression  was  also  noted  if  disc
hemorrhages and greater visual field loss was noted at the initial presentation (Leske
MC et al, 1998).
The impact of glaucoma on quality of life (QoL) is substantial and early recognition
and  treatment  is  important.  Preventing  vision  loss  from  glaucoma  means  that
secondary medical  problems  from falls  or  developing  depression  are  avoided  and
independence maintained (Bramley et al, 2008). There is a 58.6% risk of falls and
accidents due to vision imparment (Bramley et al, 2008). Glaucoma also increases the
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risk  for  hip  fracture  by  2.6  times  which  was  almost  comparable  to  osteoporosis
(Colon-Emeric CS et al, 2003).
1.2 QUALITY OF LIFE
The term “quality of life” is defined by the World Health Organization as individuals’
perception of their position in life in the context of culture and value systems in which
they live in relation to their goals, expectations, standards and concerns (World Health
Group,  1995).  It  is  a  broad  ranging  concept,  incorporating  individuals’  physical
health, psychological  state,  level  of  independence,  social  relationships,  and  their
relationship with their environment (Felce D, 1995).
QoL is multidimensional and is assessed based on an individuals’ perception (Xavier
MF et  al,  2003;  Bechetoille  A et  al,  2008).  Currently,  it  is  agreed that  QoL is  a
hierarchical model with three levels (Spilker B, 1990; Schiffer H, 1990; Janz et al,
2001; Patrick DL and Deyo DA, 1989). The first level is the overall assessment of
QoL as proposed by the World Health Organization. The second level comprises three
main  domains:  functional,  psychological  and  social  functioning.  The  third  level
corresponds to specific aspects of each of these domains (i.e anxiety or depression
specific to the psychological domain (Spilker B, 1990; Schiffer H, 1990; Janz et al,
2001; Patrick DL and Deyo DA, 1989). 
QoL  has  health  economic  implications  and  knowledge  of  its  impact,  will  help
determine at which level screening of the diesease will outweigh its cost (Hernandez
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RA et al, 2008). The main characteristic determining QoL in the elderly is resilience;
which is the emotional capability of recovering from stressing factors (Rowe JW &
Khan  RL,  1997).  The  task  of  recovering  from stress  factors  is  hampered  if  they
sustain too many emotional or psychological stressors at the same time (Sadavoy et al,
1995). QoL varies between individuals’; however the common denominator for poor
QoL is health  (Xavier MF et al, 2003).
There  are  two  ways  to  measure  QoL:  through  structured  and  non  structured
interviews. The structured instruments use scales of 0 - 5 to measure QoL comprising
of very positive, positive, neutral, negative and very negative whereas non structured
interviews allows individuals to identify the factors which contribute for their positive
or negative attribution to the QoL ( Farquhar M, 1995).
1.2.1 GLAUCOMA AND QUALITY OF LIFE
Glaucoma affects daily life through visual deterioration and the treatment (Lester M
& Zingrian M, 2002). Patients with glaucoma may experience diminished QoL for
several reasons; understanding of diagnosis, fear of functional loss, inconvenience of
treatment, side effects of treatment and cost of treatment (Lester M & Zingrian M,
2002). Though limitations of disease may only affect patients toward the later stages
of disease, it  has been noted that QoL can be affected even at early stages of the
disease (Khadka J et al, 2013; Xavier MF et al, 2011; Lamoureux EL et al,2011).
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Studies  have  found  a  relationship  between  visual  field  loss  and  declining  QoL
(Gutierrez  et  al,  1997;  Mills  RP,  1998;  Parrish  RK,  1997;  Jampel  HD,  2001).
Adjusted  mean  scores  for  QoL scores  were lower for  patients  with glaucomatous
visual field loss, compared to patients without visual field loss (Gutierrez et al, 1997;
Freeman  EE et al, 2006). Patients with glaucomatous visual field loss had the greatest
difficulty  with  driving  activities  (Freeman   EE  et  al,  2006,  Parrish  RK,  1997;
Gutierrez et al, 1997; ). This could be due to limitations in glare and dark adaptations
which exaggerate the visual field loss ( Dengler-Harles M et al, 1990).  
It has also been found that patients with the same degree of mean deviation in visual
field loss may have different location of the visual filed defect thus having a different
effect on QoL (Murato H et al,  2013; Sawada H et al,  2014). Central  visual field
defects in the better  eye negatively affects QoL as they affect activities like facial
recognition, finding objects, reading signs (Sawada H et al, 2014; Van Gestel A et al,
2010; Henderer J et al,  2009; Okomoto M et al,  2014). Inferior visual fields were
associated with poorer QoL as they affect activities like walking down the stairs (Sun
Y et  al,  2015; Black A eta  al,  2011;  Sawada H et  al,  2014;  Sumi I  et  al,  2003).
However another study found that superior hemifield defects are associated with near
activity difficulties (ChangHC et al, 2014). Therefore, early treatment is necessary to
prevent loss of QoL.
Vision loss from glaucoma causes patients to have difficulty in all aspects of daily
living including driving, walking, preparing meals, doing housework, reading; mental
health including social withdrawal and depression; side effects of treatment and fear
from blindness (Cardarelli WJ et al, 2013; Ramulu PY, 2009; Skalicky S et al, 2008;
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Perfetti  S et al,  1998; Bournias TE et al,  2004). Based on a cross sectional study,
glaucoma patients had a significantly higher risk of prevalence of impaired QoL (OR:
2.20;  95%  CI:  1.31,  3.70)  as  compared  to  healthy  subjects  (Park  et  al,  2015).
Glaucoma patients also had a significantly higher risk of impaired activity of daily
living  (OR 2.06;  95% CI:1.14,  3.71) as compared to healthy subjects  (Park et  al,
2015).
A cross sectional study comparing walking in patients with and without glaucoma
demonstrated  bilateral  glaucoma walked 0.04m/second slower (p<0.05) (Friedman
DS et al, 2006). However similar findings were not found in unilateral glaucoma as
bilateral glaucoma missed more points on visual field than did unilateral glaucoma
(Friedman DS et al, 2006). Another aspect of QoL that is affected is near and central
vision tasks i.e reading. It was noted that 43% of glaucoma patients complained of
difficulty  reading (Nelson P et  al,1999).  Patients  with  bilateral  glaucoma read  29
words/min slower than those without glaucoma (p<0.001) (Ramulu PY et al, 2008). It
was  also  noted  that  bilateral  advanced  glaucoma  patients  reading  speed  was  32
words/min slower than subjects without glaucoma (95% CI: -56,-7) (Ramulu PY et al,
2008). Older patients with distant and near vision loss are more dependent on others
for daily living activities, are less likely to partake in social and recreational activities
and  more  likely  to  have  mobility  disorders  and  falls  due  to  the  loss  in   balance
associated with visual disturbance (Lamoureux EL et al, 2009; Meada A et al, 1998;
Nakamura T et al, 1998).
QoL in patients with reduced vision were higher in individuals with lower education
and no occupation (Nirmalan PK et al, 2005). Patients without any formal education
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seemed to encounter significant difficulty in performing fine work (p = 0.005) and
doing  outdoor  activities  (p  =  0.019)  (Maharajah  KR  et  al,  2008).  Those  who
underwent  surgery  for  glaucoma  had  poorer  QoL  (Gupta  V  et  al,  2005).  The
association of systemic disease with reduction in QoL scores was found to be not
significant (Gupta V et al,  2005; Hyman LG et al,  2004). Another study however,
found the statistical significance between systemic disease and QoL scores (Lin JC
and Yang MC, 2008).
The number of glaucoma medications and the number of applications is associated
with poorer QoL (Balkrishnan R et al, 2003; Montmeyor F et al, 2000; Sherwood MB
et  al,  1998).  However  there  have  been  studies  where  the  number  of  glaucoma
medications was not predictive of QoL (Rossi GCM et al, 2010; Wilson MR et al,
1998). 
Fear of blindness was was also noted to be associated with poorer QoL (Odberg T et
al, 2001; Janz NK et al, 2007). 34% reported a moderate or a lot of worry to going
blind  at  baseline  that  decreased  to  11%  over  a  period  of  5  years.  Despite  the
decreasing trend, 50% remained slightly worried after 5 years (Janz NK et al, 2007).
The reduction in fear is due to multiple factors such as reassurance, more knowledge
and acceptance of the diagnosis (Odberg T et al, 2001; Janz NK et al, 2007).
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1.2.2 HEALTH RELATED QUALITY OF LIFE
Health related quality of life (HRQoL) refers to a person’s self perceived functioning
and well being (Schipper H, 1990). HRQoL restricts the concept of QoL to aspects
specifically related to health (Schipper H, 1990). HRQoL is an important expansion to
the normal traditional methods of assessing disease in the form of symptoms, signs
and morbidity (Konrad Pseudovs et al, 2010). It is a holistic approach to assess the
impact  of  disease  on  patients  physical,  social  and  emotional  well  being.  It  is
increasingly used to measure the effects of chronic illness on an individual’s daily life
and is regarded as the ultimate goal of all health interventions (Rubin RR & Peyrot M,
1999).  HRQoL is  a  valid  health  indicator  in  evaluating  diseases  and  is  routinely
asessed  through  questionnaires  (Zakaria  ZF  et  al,  2009).  Evidences  suggest  that
assessment of this parameter improves care on multiple levels such as improvement in
patient communication and problem identification (German PS et al, 1987; Zung WW
et  al,  1983;  Detmar  SB et  al,  2002).  This  results  in  improved patient  satisfaction
(Wasson JH et al, 1999).
Traditionally, clinicians are trained to obtain the qualitative aspects of medical history
such as vital signs but not the quantitative measurement such as HRQoL (Hahn E et
al, 2007). Patients perception of well being is often discordant with the assessment by
clinicians  (Hahn E et  al,  2007).  Assessment  of HRQoL improves  clinical  practice
through detection of psychological problems, monitoring disease and treatment and
altering of treatment plans when needed (Greenhalgh J et al, 1999; Espallargues M et
al, 2000; Lohr KN, 1992; Till JE, 1994).
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1.3 PATIENT REPORTED OUTCOMES
Patient reported outcomes are defined as ‘outcomes reported by patients’ (Bradley C,
2006). It measures any aspect of the patients health reported by the patient, free of
bias  from any other  person (Varma R et  al,  2010).  The European Committee  for
medicinal  products  for  human  use  defines  patient  reported  outcomes  as  patient’s
perception of a disease scored by the patient himself (Mapi Research Trust, 2009). It
complements objective clinical measurements and is able to assess the effectiveness
of treament.
Objective assessment of vision loss may not capture the overall impact of glaucoma
on the subject’s daily life (Hartmann CW et al, 2006). In  a cross sectional study,
comparing  a  group  of  visual  function  tests,  including  near  visual  field,  contrast
sensitivity  and  superimposed  monocular  kinetic  visual  field,  in  a  84-item
questionnaire;  found that  the  psychophysical  tests  were  the  best  predictors  of  the
perceived disability ( Ross JE et al, 1984).
Patient reported outcomes can be on general health, vision specific or disease specific
(Varma R et al, 2010; Spaeth G et al, 2006). General health related questionnaires
such as  Sickness  Impact  Profile  (SIP)  and Short  Form Health Survey 36 (SF 36)
serves to identify general health related domains. 
SF 36 was developed in 1992 by Ware and Sherbourne for use in clinical and research
practice. It is able to assess patients physical and mental status. It was designed to be
versatile and be used in a variety of diseases (Mapes et al, 2003; Patti et al, 2003;
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Strassnig  et  al,  2003).  It  contains  8  domains  (physical  functioning,  physical  role
limitation,  emotional role limitation, social functioning, bodily pain, mental health,
vitality and general health) and consists of closed ended questions (Wares et al, 1992).
Validity and reliability studies showed that the questionnaire could be used across a
variety of patients (Mc Horney CA et al, 1993; Mc Horney CA et al, 1994). However,
when SF 36 was administered to patients with glaucoma  there was weak correlation
between the SF 36 scores and visual field loss (Parrish RK et al, 1997; Jampel HD et
al, 2002). Therefore, it was difficult to attribute reduced SF 36 scores to effects of
glaucoma compared  to  other  health  conditions  that  might  concurrently  be present
(Spaeth G et al, 2006). 
Sickness  Impact  Profile  (SIP)  is  another  general  health  related  questionnaire.  It
consists  of  136  item  questionnaire  divided  into  12  categories  (body  care  and
movement,  mobility,  ambulation,  emotional behaviour, social  interaction,  alertness,
communication, sleep and rest, home management, work, recreation and pastimes and
eating) (Pollard WE et al, 1976; Bergner M et al, 1981). It contains two dimension
scores (physical health and psychosocial) and can be used across a variety of patients
(Pollard WE et al, 1976; Bergner M et al, 1981; De Bruin AF et al, 1992). A modified
SIP has been used in the Collaborative Initial Glaucoma Treatment Study (CIGTS)
correlated significantly with health status (Janz NK et al, 2001). However, it takes 20-
30  mins  to  administer  the  questionnaire  which  causes  considerable  effort  to  the
elderly.  The  use  of  proxy  respondants  such  as  family  members  showed  poor
correlation  between SIP  and the  patients’  scores  which  does  not  truly  reflect  the
patients QoL (Gilson BS et al,  1980; McCusker J et al,  1984; Goldsmith G et al,
1989).
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Vision specific questionnaire such as Visual Function Index 14 (VF 14) and National
Eye  Institute  Visual  Function  Questionnaire  (NEIVFQ)  measures  effect  of  vision
problems on activities of daily living (Yu Q et al, 1996; Mangione CM et al, 1998;
Keefe JE et al, 1999). It is more specific than general health questionnaires.
VF 14 questionnaire  was  developed  to  assess  effect  of  cataract  on  vision  related
activities (Steinberg EP et al, 1995).  It comprises of 14 questions encompassing 14
vision related activities such as reading small print, doing fine work, night driving,
daytime  driving,  reading  newspaper,  reading  signs,  writing  checks,  watching
television (Steinberg et al, 1994). Administration of VF 14 questionnaire to glaucoma
patients showed a weak to moderate correlation between the score and visual field
loss (Parrish RK et al, 1997; Jampel HD et al, 2002; NahYS et al, 2000; Guttierez P et
al,1997). VF 14 comprises of daily living and driving activites but does not include
psychosocial assessment and burden of treatment which also contributes to QoL of
glaucoma patients.
NEIVFQ  is  another  vision  specific  questionnaire  that  measures  vision  dependent
function and QoL in a variety of ocular conditions (Mangione CM, Berry S et al,
1998). It comprises of 51 questions grouped into 8 function based categories (general
vision  related  concerns,  mobiity,  reading,  social  relations  and  activities,  home
activities, self care activities and personal finances) (Mangione CM, Berry S et al,
1998).   Administration  of  NEIVFQ questionnaire  to  glaucoma  patients  showed  a
moderate correlation wih visual field loss (Mangione CM, Lee PP et al, 1998; Parrish
RK et al, 1997; Guttierez P et al, 1997). However, it does not correlate well with
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symptoms  of  glaucoma  when  NEIVFQ  was  compared  to  a  glaucoma  specific
questionnaire; the Glaucoma Symptom Scale (Lee BL et al, 1998).
Glaucoma specific  instruments  such as  the  Glaucoma  Symptom Scale  (GSS)  and
Glaucoma Quality of Life 15 (GQL 15) were developed specifically to assess visual
field loss with QoL in glaucoma patients (Spaeth G et al,  2006). GSS contains 10
items  with  regards  to  symptoms  of  glaucoma  divided  into  nonvisual  symptom
subscale  (burning/stinging,  tearing,  dryness,  itching,  soreness  and  foreign  body
sensation)  and  visual  subscale  (blurry/dim  vision,  difficulty  seeing  in  daylight,
difficulty seeing in darkness, halos around light) (Lee BL et al, 1998). GSS scores
was able to discriminate between patients with and without glaucoma (Lee BL et al,
1998). Visual acuity had modest correlation with GSS scores but did not demonstrate
association with binocular visual field changes (Noe G et al, 2003). GSS measures
only the symptom aspect of glaucoma patients. Limitation of daily activity, burden of
treatment  and  psychosocial  aspect  are  not  assessed  which  also  contributes  to
glaucoma patients QoL (Khadka J et al, 2013).
GQL 15  is  another  glaucoma  specific  instrument.  It  was  developed  by  choosing
questions that correlate best with visual field loss (Nelson P et al, 1999). It consists of
15 questions  divided into glare factor,  peripheral  vision factor,  central/near  vision
factor and outdoor mobility factor (Nelson P et al, 1999). GQL 15 was able to detect
decreased visual ability even in mild visual field loss (Nelson P et al, 2003). However,
GQL does not truly assess QoL; which is a multidimensional concept as it contains
only questions regarding visual activities (Nelson P et al, 1999; Nelson P et al, 2003)
and not the psychosocial components.
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Administering  questionnaires  in  elderly  people  need  to  be  done  through  a
conversational approach (De Vries K et al, 2014). The use of closed questions and
adherence to questionaire protocol were barriers to communication with older people
as  they  seldom  express  their  concerns  and  emotions  directly.  The  data  validity
obtained when using strict close ended questions is undermined (Isaksson U et al,
2007; Suchman L et al, 1990). Therefore, administrating questionnaire to the elderly
needs  to  be  done  in  an  engaged  conversational  manner  to  avoid  missing  cues
(Suchman L et al, 1990).
1.4.1 GLAUCOMA QUALITY OF LIFE 36 
The Glaucoma Quality of Life 36 (GlauQoL 36) questionnaire is the first available
health  related  QoL tool  specific  to glaucoma that  covers  all  stages  of the disease
(Bechetoille A et al, 2008). It comprises of 36 items, covering seven health related
QoL domains relevant to glaucoma; physiological well being, self image, daily life,
burden of treatment, driving, anxiety and confidence in health care (Bechetoille A et
al, 2008). 
The initial pilot questionnaire contained 151 items covering all aspects of HRQoL and
was written in French (Rouland el al, 2002). Questions that were misunderstood by
patients or unclear were eliminated leaving 36 questions (Rouland el al, 2002; Juniper
et al,1996). Responses by patients were ranked on a 4- or 5- mode scale and scored by
summing each domain (Rouland el al, 2002). The construct validity (i.e analysis to
assess  if  the  questionnaire  measures  what  it  was  intended  to)  is  satisfactory
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(correlation  coefficent  >0.40)  as different  domains  of  the questionnaire  assesses a
specific  aspect  of  QoL  (Campbell  et  al,  1959;  Bechetoille  A  et  al,  2008).  The
questionnaire was able to assess the QoL at different severities of glaucoma as well as
different levels of visual field loss (Bechetoille A et al, 2008; Rouland el al, 2002).
Advantages of GlauQoL 36 compared to existing HRQoL questionnaires such as VF
14,  NEIVFQ  and  GQL  15  is  that,  it  not  only  covers  aspects  related  to  daily
functioning but also on burden of treatment, mental health and self image. This allows
the  questionnaire  to  be  also  used  in  ocular  hypertensive  patients  and  glaucoma
patients that do not have problems in function yet (Sloane et al,1992; Steinberg et al,
1994; Nordmann et al, 2004; Nelson et al, 2003). 
To date, this questionnaire has been used in a French study in 2002 (Rouland el al,
2002) and its translated Malay version in a study in 2015 (Chandramohan H et al,
2015). However the translated Malay version assessed all glaucoma patients including
POAG and PACG.  There are no known studies in English that have used GlauQoL
36  in  assessing  the  QoL  in  glaucoma  patients.  The  translated  version  of  this
questionnaire in malay language will be the first to assess the QoL in POAG patients
in the Malaysian setting. 
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1.4 DEPRESSION
Depression is a broad and heterogeneous diagnosis. Depression is defined as a feeling
of depressed mood or loss of interest with at least five out of nine symptoms present
for  a  diagnosis  of  major  depression  (DSM IV;  American  Psychiatric  Association
2000). Symptoms should be present for at least 2 weeks and each symptom should be
present  at  sufficient  severity for most  of the day.  The key symptoms include low
mood, loss of interest and pleasure or loss of energy (DSM IV; American Psychiatric
Association 2000). A depressive episode may be either  idiopathic  or secondary to
another  medical  condition  or  drug  (DSM  IV;  American  Psychiatric  Association
2000).  Both the number, severity of symptoms and degree of functional impairment
determine its severity. 
Depression is projected to be the second leading cause of disability worldwide by
2020  (Murray  CJ  et  al,  1997).  The  World  Health  Organization  estimates  that
depression will  be a major burden of illness in most  developing countries (World
Health  Organization  Depression,  2011).  The  prevalence  of  depression  range from
4.8% in Spain to 35% in Turkey (Lobo A et al, 1995; Bekaroglu et al, 1991). The
prevalence of depression in the Asia-Pacific Region which ranged from 1.7 to 6.7%
is comparable to that of the Western world (Chiu E et al, 2004). Depression affects
females twice as more than males (Depression Facts and Statistics, 2011). Depression
is  the most  common mental  illness  reported  in  Malaysia  (Mukhtar  F & Tian  PS,
2011). Overall prevalence in Malaysia range between 3.9% to 46% (Kit et al, 1997;
Kadir et al, 2005; Saniah et al, 2010). 
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Risk factors for depression include gender, level of education, health, functional and
degree  of  social  support (Blazer  DG, 2002;  Bruce ML, 2002;  Izzuna NMG et  al,
2006). Marriage is known to be a protective factor for depression due to presence of
companionship (Chen RL et al, 2008; Blay SL et al, 2007; Winrow AM et al, 2005).
Depression in turn causes increased morbidity, stroke and heart failure (Mitchell AJ et
al, 2005; Jonas BS et al, 2000; Ohira T et al, 2001; Ariyo et al; 2000). 
In  the elderly population,  disability  is  a  known risk factor  for  depression (Simon
Skalicky et al, 2008). Depression causes functional impairment and imposes a burden
on individuals, communities and health services (Rashid A et al, 2010).
1.4.1 DEPRESSION IN GERIATRICS
The United Nations and Malaysian ministry of health defines the elderly or ageing
population as individuals aged 60 years and older (Health of the Elderly, WHO 1989;
Jalal  BH,  1995).  It  is  defined  as  a  biological,  sociological,  economic  and
chronological  phenomenon (Karim HA, 1997).  Worldwide,  it  is  projected that  the
elderly population will rise by 21% in the next 50 years; and by 2050 there will be an
expected  quadruple  increase  in  elderly  population  to  almost  two  billion  in  the
developing countries (Venne R, 2005). 
The  proportion  of  older  people  among  the  Malaysian  population  is  estimated  to
increase from 6.2% in 1990 to 11.3% by 2020 due to increased life expectancy, low
mortality,  declining  fertility  and  a  healthier  living  environment  (Arokiasamy  JT,
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2000). Based on the past four national censuses in Malaysia (1970, 1980, 1991 and
2000);  the proportion of younger  age is  decreasing,  while  the proportion of  older
people is on the rise (Ong, 2001) leading to inversion of the base of the pyramid. The
population of the elderly is the highest in northwest Malaysia (Rashid AK et al, 2006).
Increase  of  an  aged  population,  results  in  increase  number  of  chronic  and  non
communicable  diseases  including  mental  health  such  as  depression  (Omran  AR,
1971).
A metaanalysis study revealed worldwide prevalence of depression in the elderly to
be 4.6 to 11% (Barua et al, 2011). In US and European countries depression in the
elderly  range  from  0.9%  to  49%  (Djernes,  2006;  Blazer,  2003).  In  Malaysia,
prevalence of depression among the elderly range from 14% to 18% (Norsiah MN,
1999; Sherina MS, 2002).
In  a  cross  sectional  study done in  Malaysia,  the  prevalence  of  depression  among
elderly was 30.1% with mild depression and 9% with severe depression (Rashid A et
al, 2010).  In the same study, more females have depression (32%) compared to males
(27.7%) (Rashid A et al, 2010). The gender difference was similar to other studies
worldwide (Alexopoulos GS , 2005; Djernes JK, 2006).
Physical health was found to be the most important factor associated with depression
(Li N et al, 2016; Alexopoulos GS , 2005; Djernes JK, 2006; Cole and Dendukuri,
2003). The other risk factors associated with depression are living arrangements, sleep
disturbances,  total  income  and  bereavement  (Imran  A  et  al,  2009;  Cole  and
Dendukuri, 2003; Li N et al, 2016). 
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In addition, depression increases mortaliy and morbidity in the elderly (Mitchell AJ &
Subramaniam  H,  2005).  Suicide  is  twice  as  frequent  in  elderly  as  in  general
population (Alexopoulos GS et al, 2002). Depression is associated with increased risk
of stroke, heart failure and hospitalization (Ariyo AA et al, 2000). Therefore, early
detection and successful treatment of depression is essential.
It is difficult to diagnose depression in the elderly. The presence of multiple medical
problems and cognitive impairment complicate the diagnosis (Imran A, et al, 2009;
Kahn et al, 1975). Memory loss and cognitive impairment in the elderly (Kahn et al,
1975)  are  less frequently seen in  younger  individuals  (Yesavage JA & Brink TL,
1981). Conversely, somatic symptoms which are a key to diagnosis of depression in
the young are less useful in the elderly as they tend to have multiple medical problems
(Yesavage JA & Brink TL, 1981). Due to the presence of cognitive impairment and
high prevalence of somatic symptoms, screening tool for depression needs to be easily
understood,  minimizes  on  somatic  components  while  concentrating  on  the
psychological aspects of depression.
1.4.2 DEPRESSION AND GLAUCOMA
It has been found that a third of individuals with vision impairment report clinically
significant  depressive  symptoms  (Rees  G  et  al,  2010).  Prevalence  of  depression
among glaucoma patients ranges between 9 – 30% (Wang SY et al, 2012, Jayawant
SS et al, 2007; Mabuchi F et al, 2008; Yochim BP, 2012). In glaucoma patients, the
disease  process,  fear  of  future  vision  loss  and  potential  side  effects  of  treatment
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contributes to depression (Jampel HD et al, 2007; Wilson MR et al, 2002). There is
increased depression with increased severity of glaucoma in individuals in their 70s
(Skalicky S et al, 2008).
Studies on association of depression in glaucoma have conflicting findings. Cumurcu
et  al  found a higher  rate  of  depression  among  patients  aged 30 to  80 years  with
psedoexfoliative glaucoma compared with controls. Mabuchi et al (2008) focused on
older glaucoma patients with a mean of 64 years (SD:12.1) and found a prevalence of
10.9%. Yochim et al (2012) found a prevalence rate of 12.2% in glaucoma patients
compared to control. Wilson et al (2002) assessed depression among mild glaucoma
and controls and found the prevalence to be equivalent. Erb et al (1999) also found no
difference in depression between normal tension glaucoma and control groups.
Depression can occur regardless of the level of vision impairment (Wang ST et al,
2012). Objective measurements of glaucoma such as visual acuity, vertical cup disc
ratio and visual field defects were not associated with depression (Wang ST et al,
2012; Skalicky S et al, 2007; Jampel HD et al, 2007). This indicates that glaucoma
patients perception of the disease plays a role and it is important to counsel and allay
fears of the disease.
In a cross sectional  study,  significant predictors of depression after adjustment for
demographic  and  systemic  disease  variables  included  difficulty  performing  close
work (p=0.005), difficulty with steps (p<0.001), difficulty with side vision (p=0.001)
and difficulty driving during the daytime (p=0.004) (Wang SY et al, 2012). Another
cross  sectional  study  found  that  depression  was  associated  with  dependency
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(p<0.001),  difficulty  performing  vision  specific  roles  such as  driving,  housework,
walking (p=0.015) and distance vision activites (p=0.013) (Owsley C, 2004).
Depression significantly reduces one’s ability to adhere to treatment (Sleath B et al,
2006; Pappa C et al, 2006; Wing RR et al; 2002). This was compounded by the fact
that  elderly  glaucoma  patients  have  cognitive  impairment  resulting  in  impaired
memory  (Stryker  et  al,  2010;  Sleath  B  et  al,  2006;  Hagerman  KE et  al;  2007).
Problems with adherence is possibly due to the lost of hope for vision recovery, side
effects of treatment or lose of initiative to make the effort to adhere to treatment.
It  has been found that depression levels of glaucoma patients  decreased over time
after the initial diagnosis (Zhou C et al, 2013; Janz NK et al, 2006; Wilson MR et al,
2002).  This  is  due  to  the  initial  fear  of  blindness  and  worry  at  learning  of  the
diagnosis; which reduces over time from reassuarance, regular follow up, acceptance
and  more  knowledge  (Janz  NK  et  al,  2006;  Odberg  et  al,  2001).  Age  was  also
associated  with  fear  of  blindness  with  younger  patients  reporting  more  fear  of
blindness at onset (Janz NK et al,  2001, Odberg et al,  2011). This is due because
youger patients have more years of living with diagnosis therfore anticipating more
adverse outcomes (Janz NK et al, 2001, Odberg et al, 2011).
1.4.3 GERIATRIC DEPRESSION SCALE
There are numerous depression scales that have been developed such as Zung Rating
Scale,  Hamilton  depression  scale  and  Becks  Depression  Inventory  (Hamilton  M,
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1960; Zung WWK, 1965; Beck AT, 1996). However, these depression rating scales
have been developed and validated for the use of a younger population with many
questions measuring somatic complaints. Its applicability with older individuals are
limited as elderly population have multiple  existing medical  problems and the use
may elevate the scores of non depressed older persons (Yesavage JA & Brink TL,
1981; Heo M et al, 2007). Furthermore, the depression scales have not been validated
for the use in the elderly population (Hamilton M, 1960; Zung WWK, 1965; Carroll et
al, 1973).
The  Geriatric  Depression  Scale  (GDS)  was  developed  with  the  recognition  that
depressive  symptoms  in  elderly  patients  require  a  questionnaire  that  is  able  to
discriminate  depressive  symptoms  from  the  general  characteristics  of  the  elderly
population.  It focuses instead on the psychosocial  aspects of depression. GDS was
created initially as a 30 item questionnaire (Yesavage JA & Brink TL, 1981). It can be
self administered or presented as an interview. It consists of a yes/no format to make
the scale  simple  and easily understood by the elderly (Yesavage JA & Brink TL,
1981). GDS has a sensitivity of 92% and a specificity of 89%. (Koenig HG et al,
1998). A shorter version consisting of 15 items was later created to ease the process as
it takes 5-7 minutes to complete (Sheik J & Yesavage JA, 1986). The shorter version
was highly correlative to the long version (r = 0.84) (Herrman N et al, 1996; Lesher
EL, 1994). 
In patients with cognitive impairment, 2 studies found that the GDS score was valid
for  elderly  with  scores  above 15 out  of  30  on  a  Mini  Mental  State  Examination
(MMSE) (Jongenelis K et al, 2005; McGivney SA, 1994). However, Gerritsen et al
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(2007) noted that GDS was valid for MMSE scores of 5 or more suggesting that only
severely demented patients were not able to complete GDS. This finding was echoed
by Conradsson M et al (2013) where GDS was found to be valid for MMSE score of
10 or more. Therefore administration of GDS in cognitive impaired patients should be
done  with  their  caregiver.  Some  studies  have  demonstrated  that  the  Geriatric
Depression Scale is able to detect depression better than medical and nursing staffs
(Rapp et al, 1988; Jackson R & Baldwin B, 1993).
1.4.4 MALAY VERSION-GERIATRIC DEPRESSION SCALE-14 (mGDS 14)
The  shorter  English  version  GDS  consisting  of  15  questions  was  translated  and
validated in the Malay language in 2004 by Teh EE et al (2004) to be used in local
elderly population.  mGDS 14 was translated and validated,  leaving out question 9
(preference  of  living  at  home rather  than  going out)  as  most  elderly in  the  local
culture  are  relatively  introvert  and  emphasis  is  on  family  rather  than  individual
lifestyle  (Teh EE & Hasanah CI,  2004).  Therefore,  most  patients  gave  a  positive
response to question 9 despite their depressive state. The final questionnaire contained
14 questions which makes it easy to be adminitered in the elderly patients.
Patients with the score of 8 and above are considered depressed (Teh EE & Hasanah
CI, 2004). The mGDS 14 has satisfactory correlation with depression as a screening
scale for depressed elderly patients when the score of mGDS 14 was compared to the
clinical diagnosis of depression (Teh EE & Hasanah CI, 2004).
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